Seroprotective Titers against 2009 H1N1 Influenza A Virus after Vaccination in Allogeneic Hematopoietic Stem Cell Transplantation Recipients
Nicolas C. Issa(Dana-Farber Cancer Institute), Lindsey R. Baden(Brigham and Women's Hospital), Kelly Verrill(Boston Children's Hospital), Corey Cutler(Harvard University), John Koreth(Otsuka (Japan)), Vincent T. Ho(Dana-Farber Cancer Institute), Sophia Koo(Dana-Farber Brigham Cancer Center), Lisa S. Gagne(Brigham and Women's Hospital), Philippe Armand(Harvard University), Joseph H. Antin(Boston University), Robert J. Soiffer(Harvard University), Edwin P. Alyea(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Francisco M. Marty(Brigham and Women's Hospital)
Cited by 74
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
|New England Journal of Medicine|2014|3.5k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
|Journal of Clinical Oncology|1997|1.3k